Hypertension in Children: A Comprehensive Review of Contemporary Knowledge and Future Perspectives
DOI:
https://doi.org/10.12775/JEHS.2025.82.60282Keywords
Paediatrics, Hypertension, Risk factors, Complications, Treatment, ScreeningAbstract
Introduction: Hypertension is one of the most common, well-documented and potentially reversible risk factors of cardiovascular incidents in the adult population. However, studies are much scarcer when it comes to children. With the obesity epidemic on the rise around the world, clinicians must try and ensure the best possible care is given to the patients in order to avoid potential unfavourable outcomes.
Aim of the Study: This study aims to evaluate and summarise current knowledge regarding arterial hypertension in the paediatric population, especially emerging trends, causes, risk factors, and long-term outcomes and outline possible future avenues of research.
Materials and Methods: A systemic search of currently available literature was conducted through databases such as PubMed, Google Scholar, ResearchGate, and the Cochrane Library using combinations of keywords such as “paediatric hypertension,” “ treatment,” “screening,” “epidemiology,” and “complications.” The current guidelines by associations around the world, such as the American Academy of Pediatrics (AAP), European Society of Hypertension (ESH) and the Canadian Cardiovascular Society (CCS) were also reviewed.
Conclusions: Arterial hypertension has emerged as a condition of growing prevalence within the paediatric population. Research indicates that it is prevalent among individuals with a Body Mass Index (BMI) equal to or exceeding 25. Furthermore, the potential complications associated with this condition are numerous, and prompt diagnosis alongside effective treatment, through lifestyle modifications or pharmacotherapy, is essential to mitigate these risks. Nonetheless, numerous avenues for further research remain available to enhance understanding and treatment strategies of paediatric hypertension.
References
1. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents [published correction appears in Pediatrics. 2017 Dec;140(6):e20173035. doi: 10.1542/peds.2017-3035.] [published correction appears in Pediatrics. 2018 Sep;142(3):e20181739. doi: 10.1542/peds.2018-1739.]. Pediatrics. 2017;140(3):e20171904. doi:10.1542/peds.2017-1904
2. Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34(10):1887-1920. doi:10.1097/HJH.0000000000001039
3. Rabi DM, McBrien KA, Sapir-Pichhadze R, et al. Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2020;36(5):596-624. doi:10.1016/j.cjca.2020.02.086
4. de Simone G, Mancusi C, Hanssen H, et al. Hypertension in children and adolescents. Eur Heart J. 2022;43(35):3290-3301. doi:10.1093/eurheartj/ehac328
5. Song P, Zhang Y, Yu J, et al. Global Prevalence of Hypertension in Children: A Systematic Review and Meta-analysis. JAMA Pediatr. 2019;173(12):1154-1163. doi:10.1001/jamapediatrics.2019.3310
6. de Moraes ACF, Lacerda MB, Moreno LA, Horta BL, Carvalho HB. Prevalence of high blood pressure in 122,053 adolescents: a systematic review and meta-regression. Medicine (Baltimore). 2014;93(27):e232. doi:10.1097/MD.0000000000000232
7. Chung J, Robinson C, Sheffield L, et al. Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Hypertension. 2023;80(11):2280-2292. doi:10.1161/HYPERTENSIONAHA.123.20967
8. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298(8):874-879. doi:10.1001/jama.298.8.874
9. Miyashita Y, Hanevold C, Faino A, et al. White Coat Hypertension Persistence in Children and Adolescents: The Pediatric Nephrology Research Consortium Study. J Pediatr. 2022;246:154-160.e1. doi:10.1016/j.jpeds.2022.03.036
10. Bovet P, Hungerbuhler P, Quilindo J, Grettve ML, Waeber B, Burnand B. Systematic difference between blood pressure readings caused by cuff type [published correction appears in Hypertension 1995 Apr;25(4 Pt 1):660]. Hypertension. 1994;24(6):786-792. doi:10.1161/01.hyp.24.6.786
11. Linfors EW, Feussner JR, Blessing CL, Starmer CF, Neelon FA, McKee PA. Spurious hypertension in the obese patient. Effect of sphygmomanometer cuff size on prevalence of hypertension. Arch Intern Med. 1984;144(7):1482-1485.
12. Duncombe SL, Voss C, Harris KC. Oscillometric and auscultatory blood pressure measurement methods in children: a systematic review and meta-analysis. J Hypertens. 2017;35(2):213-224. doi:10.1097/HJH.0000000000001178
13. Sun J, Steffen LM, Ma C, Liang Y, Xi B. Definition of pediatric hypertension: are blood pressure measurements on three separate occasions necessary?. Hypertens Res. 2017;40(5):496-503. doi:10.1038/hr.2016.179
14. Bovet P, Gervasoni JP, Ross AG, et al. Assessing the prevalence of hypertension in populations: are we doing it right?. J Hypertens. 2003;21(3):509-517. doi:10.1097/00004872-200303000-00016
15. Parati G, Mancia G. Assessing the white-coat effect: which blood pressure measurement should be considered?. J Hypertens. 2006;24(1):29-31. doi:10.1097/01.hjh.0000198041.47128.05
16. Seeman T, Šuláková T, Stabouli S. Masked Hypertension in Healthy Children and Adolescents: Who Should Be Screened? [published correction appears in Curr Hypertens Rep. 2023 Nov;25(11):421. doi: 10.1007/s11906-023-01271-3.]. Curr Hypertens Rep. 2023;25(9):231-242. doi:10.1007/s11906-023-01260-6
17. Kupferman JC, Lande MB, Stabouli S, Zafeiriou DI, Pavlakis SG. Hypertension and childhood stroke. Pediatr Nephrol. 2021;36(4):809-823. doi:10.1007/s00467-020-04550-2
18. Litwin M. Pathophysiology of primary hypertension in children and adolescents. Pediatr Nephrol. 2024;39(6):1725-1737. doi:10.1007/s00467-023-06142-2
19. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642. doi:10.1016/S0140-6736(17)32129-3
20. Obesity and overweight (2024, March 1). Retrieved from https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. (Accessed on 17.03.2025)
21. Wang L, Ren L, Wang Y, et al. Effect of body mass index trajectory on hypertension among children and adolescents aged 5-18 years: a retrospective cohort study. Ann Med. 2023;55(2):2267572. doi:10.1080/07853890.2023.2267572
22. Ji Y, Zhao X, Feng Y, et al. Body mass index trajectory from childhood to puberty and high blood pressure: the China Health and Nutrition Survey. BMJ Open. 2021;11(11):e055099. Published 2021 Nov 25. doi:10.1136/bmjopen-2021-055099
23. Drozdz D, Kwinta P, Korohoda P, Pietrzyk JA, Drozdz M, Sancewicz-Pach K. Correlation between fat mass and blood pressure in healthy children. Pediatr Nephrol. 2009;24(9):1735-1740. doi:10.1007/s00467-009-1207-9
24. Wühl E. Hypertension in childhood obesity. Acta Paediatr. 2019;108(1):37-43. doi:10.1111/apa.14551
25. Kaelber DC, Localio AR, Ross M, et al. Persistent Hypertension in Children and Adolescents: A 6-Year Cohort Study. Pediatrics. 2020;146(4):e20193778. doi:10.1542/peds.2019-3778
26. Bassareo PP, Calcaterra G, Sabatino J, et al. Primary and secondary paediatric hypertension. J Cardiovasc Med (Hagerstown). 2023;24(Suppl 1):e77-e85. doi:10.2459/JCM.0000000000001432
27. Chrysaidou K, Chainoglou A, Karava V, Dotis J, Printza N, Stabouli S. Secondary Hypertension in Children and Adolescents: Novel Insights. Curr Hypertens Rev. 2020;16(1):37-44. doi:10.2174/1573402115666190416152820
28. Taha K, Catapang M, Becknell B, Matsell DG. Hypertension in children with congenital anomalies of the kidney and urinary tract. Pediatr Nephrol. 2024;39(4):1185-1192. doi:10.1007/s00467-023-06207-2
29. Hsiao W, Denburg M, Laskin B. Hypertension in Wilms tumor. Pediatr Nephrol. 2024;39(1):15-24. doi:10.1007/s00467-023-06011-y
30. Singh V, Van Why SK. Monogenic Etiology of Hypertension. Med Clin North Am. 2024;108(1):157-172. doi:10.1016/j.mcna.2023.06.005
31. MacLean PS, Higgins JA, Giles ED, Sherk VD, Jackman MR. The role for adipose tissue in weight regain after weight loss. Obes Rev. 2015;16 Suppl 1(Suppl 1):45-54. doi:10.1111/obr.12255
32. Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and Dependence: 2008 Update. Rockville (MD): US Department of Health and Human Services; 2008 May. Available from: https://www.ncbi.nlm.nih.gov/books/NBK63952/1
(Accessed on 17.03.2025)
33. Gray KM, Baker NL, McClure EA, et al. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. JAMA Pediatr. 2019;173(12):1146-1153. doi:10.1001/jamapediatrics.2019.3553
34. Gray KM, Rubinstein ML, Prochaska JJ, et al. High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial. Lancet Child Adolesc Health. 2020;4(11):837-845. doi:10.1016/S2352-4642(20)30243-1
35. Algharably EA, Meinert F, Januszewicz A, Kreutz R. Understanding the impact of alcohol on blood pressure and hypertension: From moderate to excessive drinking. Kardiol Pol. 2024;82(1):10-18. doi:10.33963/v.kp.98704
36. Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan OSM, Rehm J. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017;2(2):e108-e120. doi:10.1016/S2468-2667(17)30003-8
37. WHO report on the global tobacco epidemic 2021: addressing new and emerging products (published 27 July 2021), retrieved from https://www.who.int/publications/i/item/9789240032095 (Accessed on 17.03.2025)
38. Knutson KL, Van Cauter E, Rathouz PJ, et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Intern Med. 2009;169(11):1055-1061. doi:10.1001/archinternmed.2009.119
39. Sabanayagam C, Shankar A. Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep. 2010;33(8):1037-1042. doi:10.1093/sleep/33.8.1037
40. Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, Verschuren WM. Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: the MORGEN study. Eur J Prev Cardiol. 2014;21(11):1367-1375. doi:10.1177/2047487313493057
41. Friedman O, Logan AG. The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects. Am J Hypertens. 2009;22(5):474-483. doi:10.1038/ajh.2009.43
42. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359(9302):204-210. doi:10.1016/S0140-6736(02)07445-7
43. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5(Suppl 5):S213-S256. doi:10.1542/peds.2009-2107C
44. Gidding SS, Dennison BA, Birch LL, et al. Dietary recommendations for children and adolescents: a guide for practitioners [published correction appears in Pediatrics. 2006 Sep;118(3):1323. Gilman, Matthew W [corrected to Gillman, Matthew W]]. Pediatrics. 2006;117(2):544-559. doi:10.1542/peds.2005-2374
45. McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115(14):1948-1967. doi:10.1161/CIRCULATIONAHA.107.181946
46. Kelly RK, Thomson R, Smith KJ, Dwyer T, Venn A, Magnussen CG. Factors Affecting Tracking of Blood Pressure from Childhood to Adulthood: The Childhood Determinants of Adult Health Study. J Pediatr. 2015;167(6):1422-8.e2. doi:10.1016/j.jpeds.2015.07.055
47. Mark AE, Janssen I. Dose-response relation between physical activity and blood pressure in youth. Med Sci Sports Exerc. 2008;40(6):1007-1012. doi:10.1249/MSS.0b013e318169032d
48. Gidding SS, Barton BA, Dorgan JA, et al. Higher self-reported physical activity is associated with lower systolic blood pressure: the Dietary Intervention Study in Childhood (DISC). Pediatrics. 2006;118(6):2388-2393. doi:10.1542/peds.2006-1785
49. Cai L, Wu Y, Wilson RF, Segal JB, Kim MT, Wang Y. Effect of childhood obesity prevention programs on blood pressure: a systematic review and meta-analysis. Circulation. 2014;129(18):1832-1839. doi:10.1161/CIRCULATIONAHA.113.005666
50. Levy RV, Brathwaite KE, Sarathy H, Reidy K, Kaskel FJ, Melamed ML. Analysis of Active and Passive Tobacco Exposures and Blood Pressure in US Children and Adolescents. JAMA Netw Open. 2021;4(2):e2037936. Published 2021 Feb 1. doi:10.1001/jamanetworkopen.2020.37936
51. Belfort MB, Rifas-Shiman SL, Rich-Edwards J, Kleinman KP, Gillman MW. Size at birth, infant growth, and blood pressure at three years of age. J Pediatr. 2007;151(6):670-674. doi:10.1016/j.jpeds.2007.05.010
52. Cao Y, Zhu L, Liu J. Effects of aerobic exercise on obese children with metabolic syndrome: a systematic review and meta-analysis. J Pediatr Endocrinol Metab. 2021;34(9):1069-1079. Published 2021 Jul 22. doi:10.1515/jpem-2021-0295
53. Ekelund U, Luan J, Sherar LB, et al. Moderate to vigorous physical activity and sedentary time and cardiometabolic risk factors in children and adolescents [published correction appears in JAMA. 2012 May 9;307(18):1915. Sardinha L [corrected to Sardinha, L B]; Anderssen, S A [corrected to Anderson, L B]]. JAMA. 2012;307(7):704-712. doi:10.1001/jama.2012.156
54. Falkner B, Gidding SS, Ramirez-Garnica G, Wiltrout SA, West D, Rappaport EB. The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr. 2006;148(2):195-200. doi:10.1016/j.jpeds.2005.10.030
55. Dong Y, Song Y, Zou Z, Ma J, Dong B, Prochaska JJ. Updates to pediatric hypertension guidelines: influence on classification of high blood pressure in children and adolescents. J Hypertens. 2019;37(2):297-306. doi:10.1097/HJH.0000000000001903
56. Burrello J, Erhardt EM, Saint-Hilary G, et al. Pharmacological Treatment of Arterial Hypertension in Children and Adolescents: A Network Meta-Analysis. Hypertension. 2018;72(2):306-313. doi:10.1161/HYPERTENSIONAHA.118.10862
57. Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R. Pharmacological interventions for hypertension in children. Cochrane Database Syst Rev. 2014;2014(2):CD008117. Published 2014 Feb 1. doi:10.1002/14651858.CD008117.pub2
58. Mainieri F, Tagi VM, Chiarelli F. Treatment of Hypertension in Children. Curr Hypertens Rev. 2024;20(2):80-89. doi:10.2174/0115734021305332240712103602
59. Mead E, Atkinson G, Richter B, et al. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2016;11(11):CD012436. Published 2016 Nov 29. doi:10.1002/14651858.CD012436
60. Weghuber D, Barrett T, Barrientos-Pérez M, et al. Once-Weekly Semaglutide in Adolescents with Obesity. N Engl J Med. 2022;387(24):2245-2257. doi:10.1056/NEJMoa2208601
61. Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med. 2020;382(22):2117-2128. doi:10.1056/NEJMoa1916038
62. Burrello J, Erhardt EM, Saint-Hilary G, et al. Pharmacological Treatment of Arterial Hypertension in Children and Adolescents: A Network Meta-Analysis. Hypertension. 2018;72(2):306-313. doi:10.1161/HYPERTENSIONAHA.118.10862
63. US Preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for High Blood Pressure in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;324(18):1878-1883. doi:10.1001/jama.2020.20122
64. Chung J, Robinson CH, Yu A, et al. Risk of Target Organ Damage in Children With Primary Ambulatory Hypertension: A Systematic Review and Meta-Analysis. Hypertension. 2023;80(6):1183-1196. doi:10.1161/HYPERTENSIONAHA.122.20190
65. Dekkers JC, Snieder H, Van Den Oord EJ, Treiber FA. Moderators of blood pressure development from childhood to adulthood: a 10-year longitudinal study. J Pediatr. 2002;141(6):770-779. doi:10.1067/mpd.2002.128113
66. Juhola J, Magnussen CG, Berenson GS, et al. Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: the International Childhood Cardiovascular Cohort Consortium. Circulation. 2013;128(3):217-224. doi:10.1161/CIRCULATIONAHA.113.001614
67. Juhola J, Oikonen M, Magnussen CG, et al. Childhood physical, environmental, and genetic predictors of adult hypertension: the cardiovascular risk in young Finns study. Circulation. 2012;126(4):402-409. doi:10.1161/CIRCULATIONAHA.111.085977
68. Litwin M, Niemirska A, Sladowska J, et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol. 2006;21(6):811-819. doi:10.1007/s00467-006-0068-8
69. Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39(4):903-908. doi:10.1161/01.hyp.0000013266.40320.3b
70. Sharma AK, Metzger DL, Rodd CJ. Prevalence and Severity of High Blood Pressure Among Children Based on the 2017 American Academy of Pediatrics Guidelines. JAMA Pediatr. 2018;172(6):557-565. doi:10.1001/jamapediatrics.2018.0223
71. Obrycki Ł, Feber J, Derezinski T, Lewandowska W, Kułaga Z, Litwin M. Hemodynamic Patterns and Target Organ Damage in Adolescents With Ambulatory Prehypertension. Hypertension. 2020;75(3):826-834. doi:10.1161/HYPERTENSIONAHA.119.14149
72. Pac M, Obrycki Ł, Koziej J, Skoczyński K, Starnawska-Bojsza A, Litwin M. Assessment of hypertension-mediated organ damage in children and adolescents with hypertension. Blood Press. 2023;32(1):2212085. doi:10.1080/08037051.2023.2212085
73. Franklin SS, Wilkinson IB, McEniery CM. Unusual hypertensive phenotypes: what is their significance?. Hypertension. 2012;59(2):173-178. doi:10.1161/HYPERTENSIONAHA.111.182956
74. Sorof JM. Systolic hypertension in children: benign or beware?. Pediatr Nephrol. 2001;16(6):517-525. doi:10.1007/s004670100586
75. McEniery CM, Franklin SS, Cockcroft JR, Wilkinson IB. Isolated Systolic Hypertension in Young People Is Not Spurious and Should Be Treated: Pro Side of the Argument. Hypertension. 2016;68(2):269-275. doi:10.1161/HYPERTENSIONAHA.116.06547
76. Lurbe E, Redon J. Isolated Systolic Hypertension in Young People Is Not Spurious and Should Be Treated: Con Side of the Argument. Hypertension. 2016;68(2):276-280. doi:10.1161/HYPERTENSIONAHA.116.06548
77. Alsaeed H, Metzger DL, Blydt-Hansen TD, Rodd C, Sharma A. Isolated diastolic high blood pressure: a distinct clinical phenotype in US children. Pediatr Res. 2021;90(4):903-909. doi:10.1038/s41390-021-01369-x
78. Franklin SS, Pio JR, Wong ND, et al. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation. 2005;111(9):1121-1127. doi:10.1161/01.CIR.0000157159.39889.EC
79. Narasimhan C, Alexander T, Krishnaswami S. Pseudohypertension in a child with Williams syndrome. Pediatr Cardiol. 1993;14(2):124-126. doi:10.1007/BF00796994
80. Ostrowska-Czyżewska A, Szwed D, Barcińska J. Monogenic hypertension — state-of-the-art knowledge. Arterial Hypertens 2024;28:160-170. DOI: 10.5603/ah.102778
81. Park SJ, Shin JI. Diagnosis and Treatment of Monogenic Hypertension in Children. Yonsei Med J. 2023;64(2):77-86. doi:10.3349/ymj.2022.0316
82. Gallegos FR, Delahunty MP, Hu J, et al. Decoding Monogenic Hypertension: A Review of Rare Hypertension Disorders. Am J Hypertens. Published online January 13, 2025. doi:10.1093/ajh/hpaf005
83. Jackson SL, Zhang Z, Wiltz JL, et al. Hypertension Among Youths - United States, 2001-2016. MMWR Morb Mortal Wkly Rep. 2018;67(27):758-762. Published 2018 Jul 13. doi:10.15585/mmwr.mm6727a2
84. Flynn JT, Urbina EM, Brady TM, et al. Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association. Hypertension. 2022;79(7):e114-e124. doi:10.1161/HYP.0000000000000215
85. Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician. 2010;82(12):1471-1478.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Maciej Mozer, Przemysław Klasicki, Wiktoria Pietruszka, Wiktor Możarowski, Jan Stanisław Mateńko, Agata Krupa, Anna Krawczyk, Maria Potrykus, Julia Kiełbratowska, Michał Pałuchowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 201
Number of citations: 0
